|
OMIM |
Link |
Information gain |
01 |
|
SLE
|
[NCBI]
|
0.00231458
|
|
|
twinning, dizygotic
|
[NCBI]
|
0.000598712
|
|
|
AFP
|
[NCBI]
|
0.000578093
|
|
|
DHS
|
[NCBI]
|
0.000563334
|
|
|
diaphragmatic hernia, congenital
|
[NCBI]
|
0.000524757
|
|
|
holoprosencephaly
|
[NCBI]
|
0.000472254
|
|
|
DWS
|
[NCBI]
|
0.000465859
|
|
|
PCOS1
|
[NCBI]
|
0.000426549
|
|
|
klippel-trenaunay-weber syndrome
|
[NCBI]
|
0.00040747
|
|
|
HFM
|
[NCBI]
|
0.000347042
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
0.00023219
|
|
|
SRS
|
[NCBI]
|
0.000218079
|
|
|
CPI
|
[NCBI]
|
0.000162144
|
|
|
PXE
|
[NCBI]
|
0.000100836
|
|
|
FOLR1
|
[NCBI]
|
8.71926e-05
|
|
|
AD
|
[NCBI]
|
8.62635e-05
|
|
|
RA
|
[NCBI]
|
7.22985e-05
|
|
|
PRL
|
[NCBI]
|
5.44488e-05
|
|
|
globozoospermia
|
[NCBI]
|
5.39921e-05
|
|
|
PAEP
|
[NCBI]
|
5.16449e-05
|
|
|
AVSD
|
[NCBI]
|
5.15882e-05
|
|
|
hyperornithinemia-hyperammonemia-homocitrullinuria syndrome
|
[NCBI]
|
4.93866e-05
|
|
|
heart block, congenital
|
[NCBI]
|
4.40885e-05
|
|
|
MAS
|
[NCBI]
|
4.36795e-05
|
|
|
methionine adenosyltransferase deficiency
|
[NCBI]
|
4.26138e-05
|
|
|
LQT3
|
[NCBI]
|
4.26138e-05
|
|
|
MG
|
[NCBI]
|
4.10901e-05
|
|
|
hydatidiform mole
|
[NCBI]
|
3.8796e-05
|
|
|
osteogenesis imperfecta, type iv
|
[NCBI]
|
3.66392e-05
|
|
|
CBAVD
|
[NCBI]
|
3.66392e-05
|
|
|
long-chain 3-hydroxyacyl-coa dehydrogenase deficiency
|
[NCBI]
|
3.38318e-05
|
|
|
diastrophic dysplasia
|
[NCBI]
|
3.29889e-05
|
|
|
methylmalonic aciduria due to methylmalonyl-coa mutase deficiency
|
[NCBI]
|
3.29889e-05
|
|
|
EFE
|
[NCBI]
|
3.21855e-05
|
|
|
MTHFR
|
[NCBI]
|
3.17638e-05
|
|
|
SEDC
|
[NCBI]
|
3.14185e-05
|
|
|
ehlers-danlos syndrome, type iv, autosomal dominant
|
[NCBI]
|
3.14185e-05
|
|
|
GNRH1
|
[NCBI]
|
2.7798e-05
|
|
|
CRH
|
[NCBI]
|
2.68426e-05
|
|
|
SHBG
|
[NCBI]
|
2.58387e-05
|
|
|
HCH
|
[NCBI]
|
2.57619e-05
|
|
|
F2RL3
|
[NCBI]
|
2.52471e-05
|
|
|
MDLS
|
[NCBI]
|
2.47361e-05
|
|
|
kartagener syndrome
|
[NCBI]
|
2.47361e-05
|
|
|
CTNS
|
[NCBI]
|
2.3774e-05
|
|
|
MAT1A
|
[NCBI]
|
2.25113e-05
|
|
|
tyrosine transaminase deficiency
|
[NCBI]
|
2.25113e-05
|
|
|
HSAN3
|
[NCBI]
|
2.20155e-05
|
|
|
TFPI
|
[NCBI]
|
2.17269e-05
|
|
|
ABL
|
[NCBI]
|
2.12086e-05
|
|
|
DM2
|
[NCBI]
|
2.12086e-05
|
|
|
CMT1B
|
[NCBI]
|
2.00765e-05
|
|
|
GRA
|
[NCBI]
|
1.93689e-05
|
|
|
AMC
|
[NCBI]
|
1.9028e-05
|
|
|
FGFR3
|
[NCBI]
|
1.88009e-05
|
|
|
EPHX1
|
[NCBI]
|
1.66779e-05
|
|
|
CES
|
[NCBI]
|
1.6022e-05
|
|
|
VEGF
|
[NCBI]
|
1.59846e-05
|
|
|
TD1
|
[NCBI]
|
1.54958e-05
|
|
|
TPO
|
[NCBI]
|
1.5435e-05
|
|
|
DAZ
|
[NCBI]
|
1.52743e-05
|
|
|
MTATP6
|
[NCBI]
|
1.51514e-05
|
|
|
COL3A1
|
[NCBI]
|
1.47982e-05
|
|
|
SCN5A
|
[NCBI]
|
1.4466e-05
|
|
|
CEL
|
[NCBI]
|
1.38558e-05
|
|
|
alopecia, androgenetic
|
[NCBI]
|
1.3372e-05
|
|
|
TS
|
[NCBI]
|
1.33388e-05
|
|
|
LIPC
|
[NCBI]
|
1.31349e-05
|
|
|
osteogenesis imperfecta, type i
|
[NCBI]
|
1.29477e-05
|
|
|
CCL2
|
[NCBI]
|
1.28873e-05
|
|
|
NS1
|
[NCBI]
|
1.2144e-05
|
|
|
SLC11A2
|
[NCBI]
|
1.21352e-05
|
|
|
BLM
|
[NCBI]
|
1.17631e-05
|
|
|
LS
|
[NCBI]
|
1.17631e-05
|
|
|
wilson disease
|
[NCBI]
|
1.13952e-05
|
|
|
homocystinuria
|
[NCBI]
|
1.1116e-05
|
|
|
ABCB11
|
[NCBI]
|
1.08892e-05
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
1.06685e-05
|
|
|
ESR1
|
[NCBI]
|
9.88354e-06
|
|
|
BWS
|
[NCBI]
|
9.28228e-06
|
|
|
SLPI
|
[NCBI]
|
9.24116e-06
|
|
|
DBA
|
[NCBI]
|
8.85257e-06
|
|
|
AGER
|
[NCBI]
|
8.70809e-06
|
|
|
VHL
|
[NCBI]
|
8.44349e-06
|
|
|
PWS
|
[NCBI]
|
8.19115e-06
|
|
|
NGFB
|
[NCBI]
|
7.39107e-06
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
7.22953e-06
|
|
|
ACH
|
[NCBI]
|
7.0918e-06
|
|
|
phenylketonuria
|
[NCBI]
|
6.45483e-06
|
|
|
KSS
|
[NCBI]
|
6.4411e-06
|
|
|
RB1
|
[NCBI]
|
6.2171e-06
|
|
|
SHH
|
[NCBI]
|
5.94782e-06
|
|
|
CD
|
[NCBI]
|
5.78961e-06
|
|
|
AMH
|
[NCBI]
|
5.52076e-06
|
|
|
TNFSF10
|
[NCBI]
|
5.06663e-06
|
|
|
PTH
|
[NCBI]
|
5.00738e-06
|
|
|
PMD
|
[NCBI]
|
4.8702e-06
|
|
|
EGFR
|
[NCBI]
|
4.13439e-06
|
|
|
G6PD
|
[NCBI]
|
3.92836e-06
|
|
|
EGF
|
[NCBI]
|
3.15812e-06
|
|
|
SLOS
|
[NCBI]
|
2.90796e-06
|
|
|
F3
|
[NCBI]
|
2.39346e-06
|
|
|
TNF
|
[NCBI]
|
2.31196e-06
|
|
|
SOD2
|
[NCBI]
|
2.21726e-06
|
|
|
CF
|
[NCBI]
|
1.86939e-06
|
|
|
GFAP
|
[NCBI]
|
1.77173e-06
|
|
|
EPO
|
[NCBI]
|
1.63898e-06
|
|
|
CFTR
|
[NCBI]
|
1.33844e-06
|
|
|
CAT
|
[NCBI]
|
1.3234e-06
|
|
|
LPL
|
[NCBI]
|
1.13607e-06
|
|
|
FMF
|
[NCBI]
|
1.10495e-06
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
9.23909e-07
|
|
|
AR
|
[NCBI]
|
8.22953e-07
|
|
|
AHR
|
[NCBI]
|
7.88444e-07
|
|
|
ACHE
|
[NCBI]
|
7.48525e-07
|
|
|
GDNF
|
[NCBI]
|
6.38854e-07
|
|
|
ADA
|
[NCBI]
|
5.73131e-07
|
|
|
HGF
|
[NCBI]
|
5.6391e-07
|
|
|
APOE
|
[NCBI]
|
5.36565e-07
|
|
|
TG
|
[NCBI]
|
4.36474e-07
|
|
|
CVID
|
[NCBI]
|
2.04908e-07
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
1.29106e-07
|
|
|
AS
|
[NCBI]
|
8.66659e-08
|
|
|
DHFR
|
[NCBI]
|
6.18066e-08
|
|
|
NPPA
|
[NCBI]
|
2.74732e-08
|
|